• 1
    Kaushal V, Kaushal GP, Melkaveri SN, Metha P. Thalidomide protects endothelial cells from doxorubicine-induced apoptosis but alters cell morphology. J Thromb Haemost 2004; 2: 32734.
  • 2
    Dernell WS, Straw RC, Withrow SJ, Powers BE, Fujita SM, Yewey GS, Joseph KF, Dunn RL, Whitman SL, Southard GL. Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer delivery devices injected subcutaneously in dogs. J Drug Target 1998; 5: 3916.
  • 3
    Cervantes A, Pinedo HM, Lankelma J, Schuurhuis GJ. The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells. Cancer Lett 1988; 41: 16977.
  • 4
    Kotamjaru S, Chitambar CR, Kalivendi SV, Joseph J, Kalyanaraman B. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis. J Biol Chem 2002; 77: 1717987.
  • 5
    Yu ZW, Quinn PJ. Dimethyl sulphoxide: a review of its applications in cell biology. Biosci Report 1994; 14: 25981.
  • 6
    Lebredo L, Barrie R, Woltering EA. DMSO protects against adriamycin-induced tissue necrosis. J Surg Res 1992; 53: 625.
  • 7
    Bertelli G, Gozza A, Forno GB, Vidili MG, Silvestro S, Venturini M, Del Mastro L, Garrone O, Rosso R, Dini D. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995; 13: 28515.